NULIBRY J Code: J1809

Drug & Product Overview

HCPCS Descriptor Injection, fosdenopterin, 0.1 mg

HCPCS Added Date October 1, 2025

Manufacturer Sentynl Therapeutics

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Powder, Lyophilized, For Solution

About NULIBRY

Nulibry is a medication aligned to the HCPCS J Code: J1809 for billing, pricing, and reimbursement purposes in the United States. This Genetic Disorder medication is administered via the intravenous route and manufactured by Sentynl Therapeutics.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
42358-0295-01	Nulibry	Sentynl Therapeutics, Inc.	95	9.5 MG

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

NULIBRY Pricing & Reimbursement

J1809 Private Payer Reimbursement

$17.18 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

NULIBRY CPT Administration Codes

CPT Code	Description
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

NULIBRY Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Molybdenum cofactor deficiency (MoCD) Type A

Drug Class

Cyclic Pyranopterin Monophosphate [EPC]Cyclic Pyranopterin Monophosphate [EXT]

Frequently Asked Questions

Is there an available Nulibry billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for NULIBRY.

Are there any available Nulibry patient assistance programs?

NULIBRY patient assistance information can be found through Sentynl Therapeutics, Inc.. Visit Here →

Where can I find Nulibry prescribing information?

Nulibry prescribing information can be found through the link below. Visit Here →

Where can I find Nulibry side effect information?

Our team has not yet identified a source of prescribing information for Nulibry.

Does billing Nulibry require wastage modifiers?

CMS does not include NULIBRY (J1809) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J1809. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.